- Home
- CIM vs OPK Comparison
CIM vs OPK Comparison
Compare CIM & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIM
- OPK
- Stock Information
- Founded
- CIM 2007
- OPK 2007
- Country
- CIM United States
- OPK United States
- Employees
- CIM N/A
- OPK N/A
- Industry
- CIM Real Estate Investment Trusts
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- CIM Real Estate
- OPK Health Care
- Exchange
- CIM Nasdaq
- OPK Nasdaq
- Market Cap
- CIM 1.1B
- OPK 1.0B
- IPO Year
- CIM 2007
- OPK 1995
- Fundamental
- Price
- CIM $13.97
- OPK $1.40
- Analyst Decision
- CIM Buy
- OPK Buy
- Analyst Count
- CIM 3
- OPK 4
- Target Price
- CIM $15.50
- OPK $2.75
- AVG Volume (30 Days)
- CIM 502.6K
- OPK 2.0M
- Earning Date
- CIM 11-05-2025
- OPK 11-06-2025
- Dividend Yield
- CIM 10.55%
- OPK N/A
- EPS Growth
- CIM N/A
- OPK N/A
- EPS
- CIM 1.28
- OPK N/A
- Revenue
- CIM $312,281,000.00
- OPK $664,029,000.00
- Revenue This Year
- CIM $15.99
- OPK N/A
- Revenue Next Year
- CIM $9.70
- OPK $0.84
- P/E Ratio
- CIM $10.92
- OPK N/A
- Revenue Growth
- CIM 1.91
- OPK N/A
- 52 Week Low
- CIM $9.85
- OPK $1.11
- 52 Week High
- CIM $16.89
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- CIM 46.56
- OPK 53.61
- Support Level
- CIM $13.83
- OPK $1.34
- Resistance Level
- CIM $14.31
- OPK $1.43
- Average True Range (ATR)
- CIM 0.26
- OPK 0.04
- MACD
- CIM -0.06
- OPK -0.00
- Stochastic Oscillator
- CIM 13.33
- OPK 60.00
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.